BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

894 related articles for article (PubMed ID: 29032824)

  • 21. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
    Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.
    Bogani G; Papadia A; Buda A; Casarin J; Di Donato V; Gasparri ML; Plotti F; Pinelli C; Paderno MC; Lopez S; Perrone AM; Barra F; Guerrisi R; Brusadelli C; Cromi A; Ferrari D; Chiapp V; Signorelli M; Leone Roberti Maggiore U; Ditto A; Palaia I; Ferrero S; De Iaco P; Angioli R; Panici PB; Ghezzi F; Landoni F; Mueller MD; Raspagliesi F
    Gynecol Oncol; 2021 Apr; 161(1):122-129. PubMed ID: 33485641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
    Khoury-Collado F; St Clair C; Abu-Rustum NR
    Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node mapping reduces practice pattern variations in surgical staging for endometrial adenocarcinoma: A before and after study.
    Liu CY; Elias KM; Howitt BE; Lee LJ; Feltmate CM
    Gynecol Oncol; 2017 May; 145(2):248-255. PubMed ID: 28363672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
    Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
    Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
    Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer.
    Yu R; Matthews BJ; Beavis AL
    Curr Treat Options Oncol; 2022 Oct; 23(10):1339-1352. PubMed ID: 35980519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?
    Abu-Rustum NR; Khoury-Collado F; Pandit-Taskar N; Soslow RA; Dao F; Sonoda Y; Levine DA; Brown CL; Chi DS; Barakat RR; Gemignani ML
    Gynecol Oncol; 2009 May; 113(2):163-9. PubMed ID: 19232699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
    Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
    Gynecol Oncol; 2018 Mar; 148(3):485-490. PubMed ID: 29290489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative lymphatic mapping techniques for endometrial cancer.
    Mais V; Cirronis MG; Piras B; Silvetti E; Cossu E; Melis GB
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):83-93. PubMed ID: 21166513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study.
    Daraï E; Dubernard G; Bats AS; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Ballester M
    Gynecol Oncol; 2015 Jan; 136(1):54-9. PubMed ID: 25450151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging.
    Holloway RW; Bravo RA; Rakowski JA; James JA; Jeppson CN; Ingersoll SB; Ahmad S
    Gynecol Oncol; 2012 Jul; 126(1):25-9. PubMed ID: 22507531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
    Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
    Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
    Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
    J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.